Power Corporation of Canada (FRA:PCR)

FRA:PCR Statistics

Total Valuation

FRA:PCR has a market cap or net worth of EUR 27.82 billion. The enterprise value is 45.46 billion.

Market Cap	27.82B
Enterprise Value	45.46B

Important Dates

The next estimated earnings date is Wednesday, March 18, 2026.

Earnings Date	Mar 18, 2026
Ex-Dividend Date	Sep 29, 2025

Share Statistics

Current Share Class	582.69M
Shares Outstanding	n/a
Shares Change (YoY)	-0.72%
Shares Change (QoQ)	-0.06%
Owned by Insiders (%)	0.57%
Owned by Institutions (%)	27.99%
Float	587.94M

Valuation Ratios

The trailing PE ratio is 14.68 and the forward PE ratio is 12.10.

PE Ratio	14.68
Forward PE	12.10
PS Ratio	1.18
PB Ratio	1.01
P/TBV Ratio	26.96
P/FCF Ratio	8.41
P/OCF Ratio	7.26
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.55, with an EV/FCF ratio of 13.74.

EV / Earnings	23.99
EV / Sales	1.92
EV / EBITDA	9.55
EV / EBIT	10.89
EV / FCF	13.74

Financial Position

The company has a current ratio of 70.24, with a Debt / Equity ratio of 0.47.

Current Ratio	70.24
Quick Ratio	63.92
Debt / Equity	0.47
Debt / EBITDA	2.99
Debt / FCF	3.90
Interest Coverage	7.49

Financial Efficiency

Return on equity (ROE) is 11.26% and return on invested capital (ROIC) is 5.91%.

Return on Equity (ROE)	11.26%
Return on Assets (ROA)	0.44%
Return on Invested Capital (ROIC)	5.91%
Return on Capital Employed (ROCE)	0.67%
Revenue Per Employee	782,571
Profits Per Employee	63,168
Employee Count	30,000
Asset Turnover	0.04
Inventory Turnover	n/a

Taxes

In the past 12 months, FRA:PCR has paid 496.25 million in taxes.

Income Tax	496.25M
Effective Tax Rate	14.11%

Stock Price Statistics

The stock price has increased by +39.24% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+39.24%
50-Day Moving Average	39.40
200-Day Moving Average	34.71
Relative Strength Index (RSI)	64.88
Average Volume (20 Days)	0

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:PCR had revenue of EUR 23.48 billion and earned 1.90 billion in profits. Earnings per share was 2.92.

Revenue	23.48B
Gross Profit	12.11B
Operating Income	3.74B
Pretax Income	3.52B
Net Income	1.90B
EBITDA	4.26B
EBIT	3.74B
Earnings Per Share (EPS)	2.92

Balance Sheet

The company has 120.31 billion in cash and 12.91 billion in debt, giving a net cash position of -4.23 billion.

Cash & Cash Equivalents	120.31B
Total Debt	12.91B
Net Cash	-4.23B
Net Cash Per Share	n/a
Equity (Book Value)	27.64B
Book Value Per Share	22.48
Working Capital	131.32B

Cash Flow

In the last 12 months, operating cash flow was 3.83 billion and capital expenditures -524.39 million, giving a free cash flow of 3.31 billion.

Operating Cash Flow	3.83B
Capital Expenditures	-524.39M
Free Cash Flow	3.31B
FCF Per Share	n/a

Margins

Gross margin is 51.60%, with operating and profit margins of 15.93% and 8.21%.

Gross Margin	51.60%
Operating Margin	15.93%
Pretax Margin	14.98%
Profit Margin	8.21%
EBITDA Margin	18.14%
EBIT Margin	15.93%
FCF Margin	14.10%

Dividends & Yields

This stock pays an annual dividend of 1.53, which amounts to a dividend yield of 3.48%.

Dividend Per Share	1.53
Dividend Yield	3.48%
Dividend Growth (YoY)	2.22%
Years of Dividend Growth	3
Payout Ratio	49.70%
Buyback Yield	0.72%
Shareholder Yield	4.20%
Earnings Yield	6.81%
FCF Yield	11.90%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	5